FDA approves two new Abbott over-the-counter continuous glucose monitors
Publishing timestamp: 2024-06-10 10:50:16
Summary
Abbott received FDA clearance for two new CGMs that will be available without prescription, including one for people without diabetes. The market opportunity could be significant as it brings technology to a new population. Abbott's new systems are designed for Type 2 diabetes patients and consumers looking to improve health and wellness. Abbott's competitor Dexcom also received FDA approval for an over-the-counter CGM.
Sentiment: POSITIVE
Keywords: health care industry, technology, internet, united states, enterprise, breaking news: technology, dexcom inc, business news, abbott laboratories,
Source: https://www.cnbc.com/2024/06/10/abbott-fda-approval-libre-rio-lingo-cgm-diabetes.html